about
Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.Innate immune evasion strategies of influenza virusesType-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages.Infectious disease. Combating emerging viral threats.Into the eye of the cytokine storm.Comparative long-term effects of interferon α and hydroxyurea on human hematopoietic progenitor cells.Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity.Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.Inhibition of cellular FLICE-like inhibitory protein abolishes insensitivity to interferon-α and death receptor stimulation in resistant variants of the human U937 cell line.Activation of protein kinase C{eta} by type I interferonsFoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma cell lines.In silico analysis and experimental validation of azelastine hydrochloride (N4) targeting sodium taurocholate co-transporting polypeptide (NTCP) in HBV therapy.Sensitivity: real (interferons, odorants) and imagined (homeopathy).Looking back: editors' pick of 2008.A phase I, dose-escalation study of cyclical weekly oral temozolomide and weekly PEG-interferon alpha-2b in patients with refractory or advanced solid tumours.Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.Current Strategies for Inhibition of Chikungunya Infection.
P2860
Q27489129-854B3D0E-04A3-448C-9FDD-75F9F8D2F65FQ30374748-526F2388-47C2-4CBF-824F-3E45499945D4Q30389518-A46DC0C5-750F-43F3-983F-23ADE5A51177Q33646273-32FBAC8F-6C07-48C3-AB9A-50C35C332A50Q34025307-817AE816-0D5F-4C85-A201-E104C1780413Q35569547-77462B28-EDA6-4A24-AEBD-B26D3D2BCB00Q35804633-2188E80C-CB7C-421A-B69A-6CB7A61FF9BAQ36119271-42754FA0-B04B-4A4A-9E2B-67A5D92A2DF6Q36127898-5411DE2A-0F92-484A-BD0A-CBA3D9156B24Q37310556-5B1C6CAE-930B-4012-A6CE-171898B93C9BQ39544475-8905EF35-6242-45CF-88DB-0BE1FD408E12Q39884881-8320A005-7506-45FB-90B5-145C12C2E801Q42092099-005C2148-DE8B-4A81-83FD-117C91EDFD6AQ42210069-472C970B-0E68-41BF-9EC8-8808B0193643Q43110274-7CBF2741-7697-40B7-AED6-19328691118DQ43146771-1276C56B-F983-473B-888F-851FE5CA88FDQ44902310-5760A58F-1E56-4AE1-9447-AECF08F15E0AQ47277628-B955D29E-618E-4067-9404-AB4EEAD784D0Q54214355-6257A826-208D-45CF-899F-ECEB72163135
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Clinical uses of interferons
@ast
Clinical uses of interferons
@en
type
label
Clinical uses of interferons
@ast
Clinical uses of interferons
@en
prefLabel
Clinical uses of interferons
@ast
Clinical uses of interferons
@en
P2860
P1476
Clinical uses of interferons
@en
P2093
Robert M Friedman
P2860
P304
P356
10.1111/J.1365-2125.2007.03055.X
P407
P577
2007-12-07T00:00:00Z